Alex France Messias Monteiro

Dr. Alex France Messias Monteiro

Universidade Federal da Paraíba- UFPB
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Alex France Messias MonteiroAlex France Messias Monteiro
Alex France Messias Monteiro
JVJéssika De O Viana
Jéssika De O Viana
Anuraj NayarisseriAnuraj Nayarisseri
Anuraj Nayarisseri
EZErnestine NkwengouaTchouboun Zondegoumba
Ernestine NkwengouaTchouboun Zondegoumba
Francisco Mendonça JuniorFrancisco Mendonça Junior
Francisco Mendonça Junior
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
Neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, are understood as occurring through genetic, cellular, and multifactor pathophysiological mechanisms. Several natural products such as flavonoids have been reported in the literature for having the capacity to cross the blood‐brain barrier and slow the progression of such diseases. The present article reports on in silico enzymatic target studies and natural products as inhibitors for the treatment of Parkinson’s and Alzheimer’s diseases. In this study we evaluated 39 flavonoids using prediction of molecular properties and in silico docking studies, while comparing against 7 standard reference compounds: 4 for Parkinson’s and 3 for Alzheimer’s. Osiris analysis revealed that most of the flavonoids presented no toxicity and good absorption parameters. The Parkinson’s docking results using selected flavonoids as compared to the standards with four proteins revealed similar binding energies, indicating that the compounds 8‐prenylnaringenin, europinidin, epicatechin gallate, homoeriodictyol, capensinidin, and rosinidin are potential leads with the necessary pharmacological and structural properties to be drug candidates. The Alzheimer’s docking results suggested that seven of the 39 flavonoids studied, being those with the best molecular docking results, presenting no toxicity risks, and having good absorption rates (8‐prenylnaringenin, europinidin, epicatechin gallate, homoeriodictyol, aspalathin, butin, and norartocarpetin) for the targets analyzed, are the flavonoids which possess the most adequate pharmacological profiles.

16 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
DADanielle da Nóbrega Alves
Danielle da Nóbrega Alves
Alex France Messias MonteiroAlex France Messias Monteiro
Alex France Messias Monteiro
PNPatricia Neris
Patricia Neris
JLJosy Goldoni Lazarini
Josy Goldoni Lazarini
GAGisely Maria Freire Abílio
Gisely Maria Freire Abílio
RCRicardo Castro
Ricardo Castro
Objective: This study evaluated the antifungal activity of cinnamaldehyde on Candida spp. In vitro and in situ assays were carried out to test cinnamaldehyde for its anti-Candida effects, antibiofilm activity, effects on fungal micromorphology, antioxidant activity, and toxicity on keratinocytes and human erythrocytes. Statistical analysis was performed considering α = 5%. Results: The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of cinnamaldehyde ranged from 18.91 μM to 37.83 μM. MIC values did not change in the presence of 0.8 M sorbitol, whereas an 8-fold increase was observed in the presence of ergosterol, suggesting that cinnamaldehyde may act on the cell membrane, which was subsequently confirmed by docking analysis. The action of cinnamaldehyde likely includes binding to enzymes involved in the formation of the cytoplasmic membrane in yeast cells. Cinnamaldehyde-treated microcultures showed impaired cellular development, with an expression of rare pseudo-hyphae and absence of chlamydoconidia. Cinnamaldehyde reduced biofilm adherence by 64.52% to 33.75% (p < 0.0001) at low concentrations (378.3–151.3 µM). Cinnamaldehyde did not show antioxidant properties. Conclusions: Cinnamaldehyde showed fungicidal activity through a mechanism of action likely related to ergosterol complexation; it was non-cytotoxic to keratinocytes and human erythrocytes and showed no antioxidant activity.

7 February 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ELEmanuela Coutinho Luna
Emanuela Coutinho Luna
ILIsadora Silva Luna
Isadora Silva Luna
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
Alex France Messias MonteiroAlex France Messias Monteiro
Alex France Messias Monteiro
Marcus ScottiMarcus Scotti
Marcus Scotti
Francisco Mendonça JuniorFrancisco Mendonça Junior
Francisco Mendonça Junior
The termneglected diseasesrefers to a group of infections caused by various classes of pathogens, including protozoa, viruses, bacteria, and helminths, most often affecting impoverished populations without adequate sanitation living in close contact with infectious vectors and domestic animals. The fact that these diseases were historically not considered priorities for pharmaceutical companies made the available treatments options obsolete, precarious, outdated, and in some cases nonexistent. The use of plants for medicinal, religious, and cosmetic purposes has a history dating back to the emergence of humanity. One of the principal fractions of chemical substances found in plants are essential oils (EOs). EOs consist of a mixture of volatile and hydrophobic secondary metabolites with marked odors, composed primarily of terpenes and phenylpropanoids. They have great commercial value and were widely used in traditional medicine, by phytotherapy practitioners, and in public health services for the treatment of several conditions, including neglected diseases. In addition to the recognized cytoprotective and antioxidative activities of many of these compounds, larvicidal, insecticidal, and antiparasitic activities have been associated with the induction of oxidative stress in parasites, increasing levels of nitric oxide in the infected host, reducing parasite resistance to reactive oxygen species, and increasing lipid peroxidation, ultimately leading to serious damage to cell membranes. The hydrophobicity of these compounds also allows them to cross the membranes of parasites as well as the blood-brain barrier, collaborating in combat at the second stage of several of these infections. Based on these considerations, the aim of this review was to present an update of the potential of EOs, their fractions, and their chemical constituents, against some neglected diseases, including American and African trypanosomiasis, leishmaniasis, and arboviruses, specially dengue.

12 May 2020 in Molecules
Verified
Journal Article
Open access
PDF file
MMMayara Maia
Mayara Maia
JSJoanda Paolla Raimundo e Silva
Joanda Paolla Raimundo e Silva
TNThaís Amanda de Lima Nunes
Thaís Amanda de Lima Nunes
JSJulyanne Maria Saraiva de Sousa
Julyanne Maria Saraiva de Sousa
GRGabriela Cristina Soares Rodrigues
Gabriela Cristina Soares Rodrigues
Marcus ScottiMarcus Scotti
Marcus Scotti
Leishmaniasis is endemic in at least 98 countries. Due to the high toxicity and resistance associated with the drugs, we chose lignans as an alternative, due to their favorable properties of absorption, distribution, metabolism, excretion, and toxicity (ADMET). To investigate their leishmanicidal potential, the biological activities of a set of 160 lignans were predicted using predictive models that were built using data for Leishmania major and L. (Viannia) braziliensis. A combined analysis, based on ligand and structure, and several other computational approaches were used. The results showed that the combined analysis was able to select 11 lignans with potential activity against L. major and 21 lignans against L. braziliensis, with multitargeting effects and low or no toxicity. Of these compounds, four were isolated from the species Justicia aequilabris (Nees) Lindau. All of the identified compounds were able to inhibit the growth of L. braziliensis promastigotes, with the most active compound, (159) epipinoresinol-4-O-β-d-glucopyranoside, presenting an IC50 value of 5.39 µM and IC50 value of 36.51 µM for L. major. Our findings indicated the potential of computer-aided drug design and development and demonstrated that lignans represent promising prototype compounds for the development of multitarget drugs against leishmaniasis.

9 January 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JVJéssika de Oliveira Viana
Jéssika de Oliveira Viana
Alex France Messias MonteiroAlex France Messias Monteiro
Alex France Messias Monteiro
JFJose Maria Barbosa Filho
Jose Maria Barbosa Filho
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
Marcus ScottiMarcus Scotti
Marcus Scotti
: Due to their versatile biological activity, Azoles are widely studied in pharmacochemistry. It is possible to use them in many applications and in studies aimed at discovering antiparasitic, antineoplastic, antiviral, antimicrobial compounds; and in the production of materials for treatment of varied pathologies. Based on their biological activity, our review presents several studies that involve this class of organic compounds. A bibliographic survey of this type can effectively contribute to pharmaceutical sciences, stimulating the discovery of new compounds, and structural improvements to biological profiles of interest. In this review, articles are discussed involving the synthesis of new compounds and chemoinformatic contributions. Current applications of azoles in both the pharmaceutical and agri-business sectors are well known, yet as this research highlights, azole compounds can also bring important contributions to the fight against many diseases. Among the heterocyclics, azoles are increasingly studied by research groups around the world for application against tuberculosis, HIV, fungal and bacterial infections; and against parasites such as leishmaniasis and trypanosomiasis. Our hope is that this work will help arouse the interest of research groups planning to develop new bioactives to fight against these and other diseases.

8 December 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ÉMÉrika Paiva de Moura
Érika Paiva de Moura
NFNatan Dias Fernandes
Natan Dias Fernandes
Alex France Messias MonteiroAlex France Messias Monteiro
Alex France Messias Monteiro
HMHerbert Igor Rodrigues de Medeiros
Herbert Igor Rodrigues de Medeiros
Marcus ScottiMarcus Scotti
Marcus Scotti
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
Background: Alzheimer's disease (AD) is a very common neurodegenerative disorder in individuals over 65 years of age; however, younger individuals can also be affected due to brain damage. Introduction: The general symptoms of this disease include progressive loss of memory, changes in behavior, deterioration of thinking, and gradual loss of ability to perform daily activities. According to the World Health Organization, dementia has affected more than 50 million people worldwide, and it is estimated that there are 10 million new cases per year, of which 70% are due to AD. Methods: This paper reported a review of scientific articles available on the internet which discuss in silico analyzes such as molecular docking, molecular dynamics, and quantitative structure-activity relationship (QSAR) of different classes of natural products and their derivatives published from 2016 onwards. In addition, this work reports the potential of fermented papaya preparation against oxidative stress in AD. Results: This research reviews the most recent studies on AD, computational analysis methods used in proposing new bioactive compounds and their possible molecular targets, and finally, the molecules or classes of natural products involved in each study. Conclusion: Thus, studies like this can orientate new research works on neurodegenerative diseases, especially AD.